Thrombopoietin in Plasmodium falciparum malaria

Br J Haematol. 2000 Jun;109(3):534-6. doi: 10.1046/j.1365-2141.2000.02096.x.

Abstract

Thrombopoietin (TPO) is the key growth factor for platelet production and is elevated in states of platelet depletion. As thrombocytopenia is a common finding in malaria, we analysed TPO regulation before, during and after antimalarial treatment. Before treatment, TPO serum levels were significantly higher in patients with severe malaria (n = 35) than in patients with uncomplicated malaria (n = 44; P = 0.024), normalizing within 14-21 d of therapy. The rapid normalization of TPO levels and increase in low peripheral platelet counts after treatment indicate that the biosynthesis of TPO and its regulation in malaria patients are normal.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Kidney Injury / blood
  • Acute Kidney Injury / parasitology
  • Antimalarials / therapeutic use*
  • Artemisinins*
  • Artesunate
  • Humans
  • Malaria, Cerebral / blood*
  • Malaria, Cerebral / drug therapy
  • Malaria, Falciparum / blood*
  • Malaria, Falciparum / drug therapy
  • Platelet Count
  • Sesquiterpenes / therapeutic use*
  • Statistics, Nonparametric
  • Thrombopoietin / drug effects*

Substances

  • Antimalarials
  • Artemisinins
  • Sesquiterpenes
  • Artesunate
  • Thrombopoietin